GSA Capital Partners’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$133K	Sell	43,447 -112,432	-72%	-$487K	0.01%	1530
2025 Q4	$555K	Buy	155,879 +92,799	+147%	+$569K	0.05%	738
2025 Q3	$561K	Buy	+63,080	New	+$640K	0.05%	770
2025 Q2	–	Sell	-27,684	Closed	-$238K	–	1742
2025 Q1	$238K	Buy	+27,684	New	+$261K	0.02%	1301
2024 Q4	–	Sell	-89,299	Closed	-$507K	–	1602
2024 Q3	$507K	Sell	89,299 -131,561	-60%	-$759K	0.04%	896
2024 Q2	$932K	Buy	220,860 +199,965	+957%	+$809K	0.07%	551
2024 Q1	$106K	Buy	+20,895	New	+$118K	0.01%	1486
2023 Q3	–	Sell	-44,139	Closed	-$359K	–	1489
2023 Q2	$359K	Buy	+44,139	New	+$378K	0.04%	942
2021 Q4	–	Sell	-30,301	Closed	-$544K	–	1405
2021 Q3	$544K	Buy	30,301 +13,298	+78%	+$265K	0.06%	650
2021 Q2	$389K	Buy	+17,003	New	+$252K	0.04%	787
2021 Q1	–	Sell	-49,678	Closed	-$268K	–	1092
2020 Q4	$268K	Buy	49,678 +20,194	+68%	+$106K	0.04%	806
2020 Q3	$134K	Buy	+29,484	New	+$127K	0.02%	1088